U.S. markets open in 5 hours 13 minutes

  • S&P Futures

    3,850.75
    +5.75 (+0.15%)
     

  • Dow Futures

    31,103.00
    +7.00 (+0.02%)
     

  • Nasdaq Futures

    13,354.00
    +59.75 (+0.45%)
     

  • Russell 2000 Futures

    2,157.60
    -0.10 (-0.00%)
     

  • Crude Oil

    52.91
    -0.40 (-0.75%)
     

  • Gold

    1,868.90
    +2.40 (+0.13%)
     

  • Silver

    25.95
    +0.18 (+0.71%)
     

  • EUR/USD

    1.2137
    +0.0022 (+0.18%)
     

  • 10-Yr Bond

    1.0900
    0.0000 (0.00%)
     

  • Vix

    21.38
    -1.86 (-8.00%)
     

  • GBP/USD

    1.3736
    +0.0081 (+0.59%)
     

  • USD/JPY

    103.4800
    -0.0900 (-0.09%)
     

  • BTC-USD

    33,141.11
    -360.99 (-1.08%)
     

  • CMC Crypto 200

    656.02
    -44.59 (-6.36%)
     

  • FTSE 100

    6,744.02
    +3.63 (+0.05%)
     

  • Nikkei 225

    28,756.86
    +233.60 (+0.82%)
     

Global Immunohematology Market Research 2020-2024 | Market Planning Structure | Technavio

·4 min read

The immunohematology market is poised to grow by USD 846.80 million during 2020-2024 progressing at a CAGR of almost 8% during the forecast period.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201229005367/en/

Technavio has announced its latest market research report titled Global Immunohematology Market 2020-2024 (Graphic: Business Wire)

Worried about the impact of COVID-19 on your business? Here is an exclusive report talking about Market scenarios, Estimates, The impact of lockdown, and Customer behavior.

Get FREE Sample Report in Minutes!

The report on the immunohematology market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing demand for blood banks and its potential to increase sales.

The immunohematology market analysis includes the product, geography, key vendors, and application. This study identifies the paradigm shift toward molecular immunohematology as one of the prime reasons driving the immunohematology market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters

The immunohematology market covers the following areas:

Immunohematology Market Sizing
Immunohematology Market Forecast
Immunohematology Market Analysis

Companies Mentioned

  • Becton, Dickinson, and Co.

  • Bio-Rad Laboratories Inc.

  • Cardinal Health Inc.

  • CSL Ltd.

  • Danaher Corp.

  • Grifols SA

  • Immucor Inc.

  • Merck KGaA

  • Ortho-Clinical Diagnostics Inc.

  • Siemens Healthineers AG

Related Reports on Health Care Include:

Global Influenza Diagnostics Market- The influenza diagnostics market is segmented by end-user (hospitals and diagnostic laboratories, academic and research centers, and home care) and geography (North America, Europe, Asia, and ROW). Click Here to Get an Exclusive Free Sample Report

Global Cell Culture Market- The cell culture market is segmented by product (consumables and equipment) and geography (North America, Europe, APAC, and ROW). Click Here to Get an Exclusive Free Sample Report

Key Topics Covered:

Executive Summary

Market Landscape

  • Market ecosystem

  • Market characteristics

  • Value chain analysis

Market Sizing

  • Market definition

  • Market segment analysis

  • Market size 2019

  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary

  • Bargaining power of buyers

  • Bargaining power of suppliers

  • Threat of new entrants

  • Threat of substitutes

  • Threat of rivalry

  • Market condition

Market Segmentation by Product

  • Market segments

  • Comparison by Product

  • Analyzers and systems - Market size and forecast 2019-2024

  • Reagents - Market size and forecast 2019-2024

  • Market opportunity by Product

Market Segmentation by Application

  • Blood-related diseases

  • HIV

  • Hepatitis

Market Segmentation by End-user

  • Hospitals

  • Blood banks

  • Diagnostic laboratories

Customer landscape

Geographic Landscape

  • Geographic segmentation

  • Geographic comparison

  • North America - Market size and forecast 2019-2024

  • Europe - Market size and forecast 2019-2024

  • Asia - Market size and forecast 2019-2024

  • ROW - Market size and forecast 2019-2024

  • Key leading countries

  • Market opportunity by geography

  • Market drivers

  • Market challenges

  • Market trends

Vendor Landscape

  • Vendor landscape

  • Landscape disruption

  • Competitive scenario

Vendor Analysis

  • Vendors covered

  • Market positioning of vendors

  • Bio-Rad Laboratories Inc.

  • Cardinal Health Inc.

  • CSL Ltd.

  • Danaher Corp.

  • Grifols SA

  • Immucor Inc.

  • Merck KGaA

  • Ortho-Clinical Diagnostics Inc.

  • Siemens Healthineers AG

Appendix

  • Scope of the report

  • Currency conversion rates for US$

  • Research methodology

  • List of abbreviations

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201229005367/en/

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Latest Stories

  • Jim Cramer: Here Are the Biden Stocks

    As power has changed hands in the White House, we can expect these names -- and themes -- to benefit.

  • The Biden Boom Is Coming And These Stocks Could Soar

    With the Biden Administration likely to pump trillions into green energy infrastructure in the coming years, renewable stocks should outperform the market

  • 3 Stocks That Could Win Big As The Biden Administration Takes The Wheel

    This year has already started with a bang, and with a “blue wave” looming over the United States, three industries could be ready to explode

  • Are These 3 Electric Car Stocks Still Worth Buying? Analyst Weighs In

    Electric cars are growing in popularity, a trend fueled by social acceptance, the green mentality, and a recognition that the internal combustion engine does have its flaws. Some of those flaws are addressed by electric vehicles (EVs). They bring lower emissions, less pollution from the car, and the promise of high performance off the mark. For the present, the main drawbacks are the high cost and relatively short range of current battery technology. Even so, many consumers have decided that the benefits outweigh the costs, and EV sales are increasing. China, in particular, has long been known for its pollution and smog issues, and the government is actively pushing EVs as a possible ameliorating factor. In addition, EVs, with their quick acceleration and (usually) short range, are a ready fit with China’s crowded – and growing – urban centers. In a comprehensive review of the Chinese EV sector, Jefferies analyst Alexious Lee noted, "We are constructive on the outlook for NEV in China as the country pushes forward with the 'electrification to digitalization' trend. While global automakers' JVs are quickly rolling out new models of energy saving vehicles (HEVs and PHEVs) to comply with the top-down target to reduce annual Corporate Average Fuel Consumption (CAFC), Chinese automakers (both legacy and startups) are motivated to quickly accelerate the adoption of BEV with entry-level, city commuting models and premium-positioned advanced models." Against this backdrop, Lee has picked out one Chinese EV stock that is worth owning, and two that investors should avoid for now. We used TipRanks' database to find out what other Wall Street analysts have to say about the prospects of these three. Li Auto (LI) Chinese EV company Li Auto boasts of having the country’s single best-selling model of electric vehicle. The Li ONE sold 3,700 units this past October, bringing the total number sold in the first year of production to 22,000. At current sales and production rates, Li expects the company to double its annual sales number this year. That’s a big deal, in the world’s largest electric car market. China produces more than half of all EVs sold globally, and nearly all of the electric busses. Li Auto, founded in 2015, has focused on plug-in hybrids – models which can plug into a charging station to maintain the battery, but also have a combustion engine to compensate for low-density charging networks. The Li ONE is a full-size SUV hybrid electric that has rapidly found popularity in its market. Li Auto went public on the NASDAQ in July of 2020. In the IPO, the company started with a share price of $11.50, and closed the first day with a gain of 40%. In the months since, LI has appreciated 116%. Those share gains come as the company reported strong earnings. In 3Q20, the last quarter reported, LI showed US$363 million in sales, up 28% sequentially, and forming the lion’s share of the company’s US$369.8 million in total revenue. Also positive, Li reported a 149% sequential increase in free cash flow, to US$110.4 million. Lee is impressed with Li Auto’s technology, noting, “Li One’s EREV powertrain has proven a great success due to (1) extended range, (2) limited impact from low temp, (3) easier acceptance by car buyers. The advantage is sustainable ahead of the battery cost parity, estimated at FY25 (LFP) and FY27 (NMC), making LI AUTO the automaker to turn OCF positive and profitable earlier vs peers." The analyst added, "LI AUTO is the first in China to successfully commercialized extended-range electric vehicle (EREV) which is solution to drivers’ range anxiety and automakers’ high BOM. Powered by fuel, the ER system provides alternative source of electricity in addition to battery packs, which is significantly outstanding during low temp environment where BEVs may lose up to 50% of the printed range." Seeing the company’s technology as the key attraction for customers and investors, Lee initiated his coverage of LI with a Buy rating and a $44.50 price target. This figure implies 25% upside growth in the year ahead. (To watch Lee’s track record, click here) There is broad agreement on Wall Street with Lee that this stock is a buying proposition. LI shares have a Strong Buy consensus rating, based on 6 reviews, including 5 Buys and 1 Hold. The shares are priced at $35.60 and the $44.18 average price target is in-line with Lee’s, suggesting 24% upside for the next 12 months. (See LI stock analysis on TipRanks) Nio (NIO) Where Li Auto has the single best-selling EV model in China, competing company Nio is vying with Elon Musk’s Tesla for the top market-share spot in the Chinese EV market. With a market cap of $90 billion, Nio is the largest of China’s domestic electric car manufacturers. The company has a varied line-up of products, including lithium-ion battery SUVs and a water-cooled electric motor sports car. Two sedans and a minivan are on the drawing boards for future release. In the meantime, Nio’s vehicles are popular. The company reported 43,728 vehicle deliveries in 2020, more than double the 2019 figure, and the last five months of the year saw car deliveries increase for 5 straight months. December deliveries exceeded 7,000 vehicles. Nio’s revenues have been increasing steadily, and has shown significant year-over-year gains in the second and third quarters of 2020. In Q2, the gain was 137%; in Q3, it was 150%. In absolute numbers, Q3 revenue hit $654 million. However, with shares rallying 1016% over the past 52 weeks, there's little room for further growth -- at least according to Jefferies' Lee. The analyst initiated coverage on NIO with a Hold rating and $60 price target. This figure implies a modest 3% upside. "We use DCF method to value NIO. In our DCF model, we factor in solid volume growth, positive net profit from FY24 and positive FCF from FY23. We apply a WACC of 8.1% and terminal growth rate of 5% and come to target price of US$60," Lee explained. Overall, Nio holds a Moderate Buy rating from the analyst consensus, with 13 reviews on record, which include 7 Buys and 6 Holds. NIO is selling for $57.71, and recent share gains have pushed that price just slightly below the $57.79 average price target. (See Nio stock analysis on TipRanks) XPeng, Inc. (XPEV) XPeng is another company, like Li, in the mid-range price level of China’s electric car market. The company has two models in production, the G3 SUV and the P7 sedan. Both are long-range EV models, capable of driving 500 to 700 kilometers on a single charge, and carry advanced autopilot systems for driver assistance. The G3 started deliveries in December 2018; the P7, in June 2020. In another comparison with Li Auto, XPeng also went public in the US markets in summer 2020. The stock premiered on the NYSE on the last day of August, at a price of $23.10, and in the IPO the company raised $1.5 billion. Since the IPO, the stock is up 127% and the company has reached a market cap of $37.4 billion. Increasing sales lie behind the share gains. XPeng reported 8,578 vehicles delivered in Q3 2020, a gain of 265% from the year-ago quarter. The bulk of those deliveries were P7 sedans – the model saw deliveries jump from 325 in Q2 to 6,210 in Q3. Strong sales translated to revenues of US$310 million for the quarter, a truly impressive gain of 342%. Jefferies' Lee sees XPeng as a well-positioned company that has possibly maxed out its short-term growth. He writes, “XPENG has a very strong exposure to tech-driven growth… While we favor its specialty in autonomous driving and power consumption efficiency, our FY21 forecast of 120% sales growth is lower than consensus while our FY22 forecast of 129% is higher given slower market acceptance and higher competition in Rmb200-300K segment.” To this end, Lee rates XPEV a Hold and his $54.40 price target suggests a minor upside of ~4%. The recent gains in XPEV have pushed the price right slightly above the average price target of $51.25; the stock is now selling for $52.46. This comes along with a Moderate Buy analyst consensus rating, based on 8 reviews, breaking down to 5 Buys, 2 Holds, and 1 Sell. (See XPEV stock analysis on TipRanks) To find good ideas for EV stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights. Disclaimer: The opinions expressed in this article are solely those of the featured analyst. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

  • Bitcoin Sells Off on Bearish Sentiment, Yellen Worries

    The sell-off also led to major corrections for other cryptocurrencies including ether, stellar, xrp and chainlink.

  • Your next stimulus check — for $1,400 — is about to start moving closer

    Congressional leaders plan to get "right to work" on it. How soon might you get the cash?

  • A survey says we're keeping too much money in cash — do this instead

    You can be too safe with your money, even during a pandemic.

  • Top Technology Stocks for February 2021

    These are the technology stocks with the best value, fastest growth, and most momentum for February 2021.

  • Stock Market Today With Jim Cramer: Buy Ford

    Jim Cramer discusses the latest stock market news including Ford stock, Procter & Gamble's earnings and the executive orders by president Joe Biden.

  • 12 red flags that could lead to an IRS audit

    IRS audit flags can stem from things you do — or don't do — when filing your tax return.

  • Obalon Therapeutics stock soars to lead all gainers on massive volume after ReShape merger deal

    Shares of Obalon Therapeutics Inc. blasted six-fold higher on massive volume in afternoon trading Wednesday, after the weight loss technologies company announced an agreement to merge with weight loss solutions company ReShape Lifesciences Inc. . Obalon's stock rose 503.4% toward the highest close since JUne 2019, while trading volume soared to 395.4 million shares, compared with the full-day average of about 626,000 shares. The stock was the biggest gainer and most active on major U.S. exchanges on Wednesday. ReShape shares, which currently trade over the counter, rose 155%. When the merger is completed, ReShape shareholders will own 51% of the combined entity, and the company will be renamed Reshape Lifesciences Inc. and will trade on the Nasdaq under the ticker symbol "RSLS." "We are excited with this opportunity to add Obalon's FDA approved Balloon System to ReShape's line of minimally invasive weight-loss solutions while also expanding our market reach," said ReShape Chief Executive Bart Bandy. Obalon's stock has now rocketed 922.5% over the past three months while ReShape shares have soared 187.3% and the S&P 500 has gained 12.0%.

  • Ethereum surges near all-time highs, may rally 650% to $10,500: analysts

    Ethereum, the second largest cryptocurrency behind bitcoin, could see a 650% rally to hit $10,500, according to analysts at Fundstrat.

  • Is Nio Stock A Buy As China EV Leader Surges After Unveiling Luxury Sedan?

    Nio stock jumped after the Chinese EV maker unveiled its first long-battery-life electric car in January. But is the stock a buy now?

  • 8 Quality Dividend Stocks for Durable Growth and Income

    From "Dividend Aristocrats" to special situations, Ben Reynolds -- along with his co-editors Bob Ciura and Nikolaos Sismanis -- provides in-depth research on high-quality stocks through its four top-ranked newsletters. Scale is a critical competitive advantage in the industry. The company's durable competitive advantage -- and shareholder friendliness -- is on display with its long dividend history.

  • Wall Street is in its riskiest mindset in 20 years: BofA survey

    Wall Street is loving the stock market as Joe Biden takes over as president, according to the latest Bank of America global fund manager survey.

  • FuelCell Energy's Earnings Outlook

    FuelCell Energy (NASDAQ:FCEL) will be releasing its next round of earnings this Thursday, January 21. For all of the relevant information, here is your guide for Thursday's Q4 earnings announcement.What Are Earnings, Net Income, And Earnings Per Share? Earnings and EPS are useful metrics of profitability. Total earnings also known as net income is equal to total revenue minus total expenses. Dividing net income by the total number of shares outstanding yields EPS.Earnings And Revenue Based on FuelCell Energy management projections, analysts predict EPS of $0.04 on revenue of $17.05 million. In the same quarter last year, FuelCell Energy reported a loss per share of $0.12 on revenue of $11.04 million.What Are Analyst Estimates And Earnings Surprises, And Why Do They Matter? Analysts who cover this company will publish forward-looking estimates of its revenue and EPS each quarter. Averaging together every EPS and revenue prediction that each analyst makes about a company in a quarter yields the "consensus estimates." A company posting earnings or revenue above or below the consensus estimate is known as an "earnings surprise" and may move the stock by a considerable margin.View more earnings on FCELThe Wall Street estimate would represent a 66.67% increase in the company's earnings. Revenue would be up 54.42% from the year-ago period. In comparison to analyst estimates in the past, here is how the company's reported EPS stacks up:Quarter Q3 2020 Q2 2020 Q1 2020 Q4 2020 EPS Estimate -0.06 -0.07 -0.08 -0.11 EPS Actual -0.07 -0.07 -0.20 -0.12 Revenue Estimate 16.05 M 15.55 M 14.91 M 11.51 M Revenue Actual 18.73 M 18.88 M 16.26 M 11.04 M Stock Performance Shares of FuelCell Energy were trading at $18.125 as of January 19. Over the last 52-week period, shares are up 884.1%. Given that these returns are generally positive, long-term shareholders are probably satisfied going into this earnings release.Do not be surprised to see the stock move on comments made during its conference call. FuelCell Energy is scheduled to hold the call at 10:00:00 ET and can be accessed here.See more from Benzinga * Click here for options trades from Benzinga * Understanding FuelCell Energy's Unusual Options Activity * 12 Industrials Stocks Moving In Friday's Intraday Session(C) 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Cramer Gives His Opinion On Canopy Growth, Quanta Services And More

    On CNBC's "Mad Money Lightning Round," Jim Cramer said he would rather buy Penn National Gaming, Inc (NASDAQ: PENN) and Draftkings Inc (NASDAQ: DKNG) instead of Fubotv Inc (NYSE: FUBO).Cramer would be careful with Nano Dimension Ltd - ADR (NASDAQ: NNDM) because of a big move higher. These moves tend to have another leg up, but he doesn't want to be too aggressive.Canopy Growth Corp (NASDAQ: CGC) is a way to play the marijuana space, thinks Cramer.CIIG Merger Corp (NASDAQ: CIIC) is a good spec, said Cramer.Everything Michael Klein has been involved with, Cramer has liked it. But he thinks Churchill Capital Corp IV (NYSE: CCIV) is speculative.Quanta Services Inc (NYSE: PWR) has more room on the upside, thinks Cramer.See more from Benzinga * Click here for options trades from Benzinga * Tony Zhang Sees More Upside to GM, Lays Out Bullish Options Trade * Carter Worth And Mike Khouw's XLU Trade(C) 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • UPDATE: Bionano Genomics prices $200 million underwritten stock offering at a discount of $6 a share

    Bionano Genomics Inc. priced a $200 million underwritten stock offering announced late Tuesday at a discount of $6 a share, selling 33.3 million shares. The stock closed Tuesday at an alltime high of $9.14. The genome sequencing company's shares have gained 662% in the last 12 months on little news flow, and trading volumes have been active in recent sessions. Bionano previously sold 29 million shares at $3.05 a share less than two weeks ago. The stock fell 22% in premarket trade to reflect the dilutive effect of the offering. Oppenheimer was sole bookrunner on the deal with BITG acting as lead manager and Ladenburg Thalmann and Maxim Group acting as co-managers. Underwriters have a 30-day option to purchase another 5 million shares at the offering price. Bionano shares traded for less than $1 for much of 2020, before prices shot higher just before the end of the year despite no public announcements about changes at the genome-analysis company, which lost nearly $30 million on sales of $4.5 million in the first nine months of 2020.

  • Biden Revokes Keystone XL Pipeline Permit to Cross U.S. Border

    (Bloomberg) -- Joe Biden canceled the Keystone XL oil pipeline hours after becoming president, killing once again a cross-border project that had won a four-year reprieve under his Republican predecessor, Donald Trump.In one of his first major environmental actions, Biden on Wednesday revoked TC Energy Corp.’s pipeline permit, according to a person familiar with the orders Biden signed.The move brings Keystone’s fate full circle, repeating a decision made in 2015 by President Barack Obama to keep the pipeline from crossing the border. Trump reversed that in 2017 on his fourth full day in office over the objections of environmental groups.TC Energy said it was “disappointed” and would suspend work on the project, leading to the layoff of thousands of workers. The decision overturns “an unprecedented, comprehensive regulatory process that lasted more than a decade and repeatedly concluded the pipeline would transport much-needed energy in an environmentally responsible way,” said the Calgary-based company.TC Energy shares closed down 1.15%, to C$55.92 in Toronto trading.Environmentalists are counting on the latest rejection -- coming more than a dozen years since the pipeline was first proposed -- to stick. They argue the project would provide an outlet for heavy Canadian oil sands crude extracted in Alberta through particularly energy-intensive processes that ratchet up its carbon footprint.“Putting a stop to the dirty and dangerous Keystone XL tar sands pipeline immediately and once and for all would be an important first step and testament to the leadership of the diverse grassroots movement that has long pushed to stop it and other harmful pipelines,” said Tiernan Sittenfeld, a senior vice president with the environmental group League of Conservation Voters.The U.S. Chamber of Commerce was critical of the decision.“The pipeline -- the most studied infrastructure project in American history -- is already under construction and has cleared countless legal and environmental hurdles,” Marty Durbin, president of the chamber’s Global Energy Institute, said in a statement. “This is a politically motivated decision that is not grounded in science.”Biden promised the action on the campaign trail, yet his formal step still provoked outrage from oil industry leaders, some Canadian interests and labor unions that support the project.“The Biden administration has chosen to listen to the voices of fringe activists instead of union members and the American consumer on Day 1,” said the United Association of Union Plumbers and Pipefitters in an emailed statement based on news reports before the action.Construction of Keystone XL already began last year, jump started with a $1.1 billion investment by the province of Alberta. Whole segments of the line, including one that crosses to U.S.-Canadian border, have already been built.TC Energy has worked to make the project more palatable to a Democratic administration, inking labor agreements with four major pipeline unions last August, agreeing to sell an equity stake in the line to indigenous communities along the route and promising to power it entirely with renewable energy.Still, Keystone XL has been a lightning rod for controversy and a litmus test for environmentalism almost since it was first proposed in 2005. The 1,179 mile (1,897 kilometer) segment is designed to move oil from Alberta through Montana, South Dakota and Nebraska, then connect with an existing network feeding crude to the Gulf Coast. The line would carry as much as 830,000 barrels of oil a day.Opponents argue it will stimulate oil sands development, contributing to climate change.Years ago, proponents of the controversial crude pipeline argued that more of Canada’s cheaper, heavy crude would help fuel producers on the U.S. Gulf Coast wean off supplies from countries like Venezuela or the conflict-prone Middle East.But refiners in Texas and Louisiana have become increasingly flexible, using more of the abundant light oil from shale fields. Plus, Canadian crude’s price advantage has narrowed, and imports from the country have roughly doubled in a decade to a steady flow of more than 3.5 million barrels a day, without Keystone XL.“It’s not an issue for refiners,” said Robert Campbell, head of oil products research at Energy Aspects Ltd. “They can switch into domestic light. The hurt would be on oil sands producers.”Sandy Fielden, director of oil research at Morningstar Inc., said doing away with Keystone in the short run won’t affect the supply of Canadian oil because of plans to expand another line and use existing infrastructure.“Those will be sufficient to meet local needs at least for now,” Fielden wrote in a statement. “If anything, scrapping the Keystone XL system would favor U.S. buyers since it would cause a backup of supplies in Canada that would ultimately pressure prices lower and more attractive.”From the archive -- Why the Keystone Project Is Controversial: QuickTakeCanadian Prime Minister Justin Trudeau expressed disappointment in the pipeline decision.“While we welcome the president’s commitment to fight climate change, we are disappointed,” Trudeau said in a statement. “I look forward to working with President Biden to reduce pollution, combat climate change, fight COVID-19, create middle class jobs, and build back better by supporting a sustainable economic recovery for everyone.”Keystone XL was one of only a handful of energy and mining projects Biden took an explicit stand against while on the campaign trail. Environmentalists emboldened by his move on Keystone are already pressuring him to revoke a critical authorization allowing continued operation of Energy Transfer LP’s Dakota Access oil pipeline and take action against Enbridge Inc.’s plan to replace and expand its aging Line 3 pipeline from Alberta to Superior, Wisconsin.“It’s exciting news,” said Dallas Goldtooth, an organizer with the Indigenous Environmental Network. “Now what are you going to do about Line 3 and the Dakota Access pipeline? We are happy, but we want to see what comes next.”For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Top Dividend Stocks for February 2021

    These are the top dividend stocks in the Russell 1000 with the highest forward dividend yield for February.